Publications by authors named "Antonia Reimer-Taschenbrecker"

Article Synopsis
  • Recessive dystrophic epidermolysis bullosa (RDEB) is a severe skin condition that causes blisters and other complications, and this study tested the safety of losartan, a medication that may slow its progression.
  • The study was a phase 1/2 trial involving children aged 2-16 with confirmed RDEB, focusing on identifying any serious side effects of losartan over a treatment period of 10 months.
  • Primary safety concerns monitored included severe drops in blood pressure, allergic reactions, and changes in potassium levels, along with evaluating the drug's effectiveness through various clinical scores.
View Article and Find Full Text PDF

Background: Invasive cutaneous squamous cell carcinomas (cSCC) are a leading cause of death in recessive dystrophic epidermolysis bullosa (RDEB), a rare blistering genodermatosis. Outcomes of RDEB-cSCC therapies have primarily been described in case reports. Systematic studies are scarce.

View Article and Find Full Text PDF

Nutritional compromise, low levels of vitamin D, chronic inflammation, abnormal growth, and physical inactivity affect bone metabolism and compromise long-term bone health in individuals with epidermolysis bullosa (EB). The result is a high risk for osteopenia, osteoporosis, and pathologic fractures, but this important consequence of EB has been the focus of few investigations. Our scoping review found 21 publications that assessed the current understanding and clinical practices for monitoring of osteoporosis and its treatment in EB.

View Article and Find Full Text PDF

Background: Race and socioeconomic status are thought to influence the severity of atopic dermatitis (AD), but findings differ between countries and measures used. The role of social determinants of health versus biologic factors in causing these differences is poorly understood.

Objective: We hypothesized that spatially-derived factors correlate with AD severity and patient-reported outcome (PRO) in a pediatric cohort from Chicago, USA.

View Article and Find Full Text PDF

Augmented intelligence (AI), the combination of artificial based intelligence with human intelligence from a practitioner, has become an increased focus of clinical interest in the field of dermatology. Technological advancements have led to the development of deep-learning based models to accurately diagnose complex dermatological diseases such as melanoma in adult datasets. Models for pediatric dermatology remain scarce, but recent studies have shown applications in the diagnoses of facial infantile hemangiomas and X-linked hypohidrotic ectodermal dysplasia; however, we see unmet needs in other complex clinical scenarios and rare diseases, such as diagnosing squamous cell carcinoma in patients with epidermolysis bullosa.

View Article and Find Full Text PDF

Background: A trio exome sequencing study identified a previously unreported NLRP1 gene variant resulting in a p.Leu813Pro substitution of the LRR (leucine-rich repeats) domain of the NLRP1 protein (NACHT, LRR and PYD domains-containing protein 1). This homozygous mutation was shared by two sisters with different clinical presentation: the younger sister had generalized inflammatory nodules with keratotic plugs, clinically resembling multiple keratoacanthomas, while the older had manifestations of familial keratosis lichenoides chronica.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on caregiver satisfaction and experiences with G-tubes in children with epidermolysis bullosa (EB), highlighting the benefits of this nutritional support intervention despite initial parental apprehension.
  • Conducted through an anonymous 89-item online survey among caregivers from nine institutions, the findings revealed that most caregivers reported high satisfaction levels (90%) post-G-tube placement and some wished they had adopted it earlier.
  • Results indicate improved mealtime experiences for both caregivers and children with EB after G-tube insertion, suggesting that caregiver feedback can guide future research and practices in managing G-tubes.
View Article and Find Full Text PDF
Article Synopsis
  • Epidermolysis bullosa (EB) is a rare genetic skin disorder causing blisters to form on the skin and mucous membranes, with varying severity among patients.
  • A study conducted in Germany found an EB incidence of 45 cases per million live births, with higher rates for junctional EB compared to other countries, possibly due to better early genetic diagnosis.
  • With estimates of around 2000 EB patients in Germany, the findings aim to influence healthcare policies, drug development strategies, and support patient advocacy efforts for improved quality of life.
View Article and Find Full Text PDF

Recessive dystrophic epidermolysis bullosa is characterized by skin blistering and wounds. To uncover the changes in the skin and mucosal microbiome related to age and disease progression and microbiome impact on clinical and inflammatory laboratory parameters, swabs from wounded and unwounded skin, oral mucosa, and stool samples of 28 children with recessive dystrophic epidermolysis bullosa and 28 healthy controls were subjected to 16S-ribosomal RNA gene sequencing. Skin microbiome of patients with recessive dystrophic epidermolysis bullosa showed significantly reduced alpha diversity compared with that of healthy controls and showed significantly early, age-dependent predominance of Staphylococcus aureus, first in wounded skin and then in unwounded skin.

View Article and Find Full Text PDF